Enernet Global Signs Power Purchase Agreement for 12MW Solar With Vedanta Zinc International in South Africa
Globe Newswire8-09-2023, 09:18
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00
